Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia von Almutairi, Abdulaali R, Alruthia, Yazed, Alyami, Majed S, Alshaya, Omar A, Alanazi, Taif Z, Al Daghreer, Sarah I, Korayem, Ghazwa B, Alrasheed, Sarah A, Alorf, Reema A, Almohammed, Omar A

Volltext